Evgen Pharma plc (EVG) Ordinary 0.25p
Evgen Pharma plc Ordinary 0.25p
- Type:
- Miscellaneous
- Shareholder action required:
- Yes
- Status:
- Update Pending
- Add to watchlist
- Create an alert
- This stock can be held in a
Evgen Pharma plc Ordinary 0.25p
- Type:
- Miscellaneous
- Shareholder action required:
- Yes
- Status:
- Update Pending
Evgen Pharma plc Ordinary 0.25p
- Type:
- Miscellaneous
- Shareholder action required:
- Yes
- Status:
- Update Pending
0.80p
0.82p
4.05p
£3.42 million
0.80p
0.82p
0.75p
n/a
0.00p (0.00%) Previous:
0.00p
227,410
n/a
30,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/03/2023 | 31/03/2022 |
---|---|---|
Revenue (£m) | 0.44 | n/a |
Profit before tax (£m) | (5.01) | (3.17) |
Adjusted EPS (p): | (1.47) | (0.99) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Evgen upbeat on start of glioblastoma research project
26 October 2023 11:08
-
Evgen Pharma doses first volunteers in SFX-01 trial
16 November 2022 14:05
-
Evgen starts recruiting volunteers for trial of lead asset
12 October 2022 12:23
-
Holding(s) in Company
22 April 2024 10:11
-
Holding(s) in Company
11 April 2024 15:04
-
Holding(s) in Company
9 April 2024 07:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.